Conditions TMS Can Treat
TMS (Transcranial Magnetic Stimulation) is a non-invasive, office-based therapy that targets mood-related brain circuits. Below is a practical guide to **FDA-cleared uses** and **emerging/adjacent** applications, plus candidacy basics.
FDA-Cleared Indications
Major Depressive Disorder (MDD)
TMS is FDA-cleared for adults with major depressive disorder, including cases that did not respond to antidepressants or caused intolerable side effects.
- Typical course: ~30 sessions over 6 weeks + taper
- No anesthesia, no systemic medication effects
- Measure progress with validated scales (PHQ-9, HDRS, MADRS, BDI)
See insurance details: Insurance & Pricing or Aetna Coverage.
Obsessive-Compulsive Disorder (OCD)
Certain TMS devices/protocols have FDA clearance for OCD. Treatment plans are individualized and may differ from depression protocols.
- Evaluation confirms diagnosis and symptom severity
- Often combined with ERP-based psychotherapy
- Coverage varies by plan and device
Ask us about device availability and your plan’s policy.
Smoking Cessation (Specific Devices)
Some deep TMS systems carry an FDA clearance for short-term smoking cessation support. Not all centers offer this indication.
Insurance coverage for this indication varies; many plans consider it limited or not covered.
Emerging or Adjacent Uses (Evidence Evolving)
There is ongoing research into TMS for additional conditions. Some insurers consider these **investigational** or require case-by-case review. We will verify your benefits and advise on options.
Anxious Depression & Postpartum Depression
Many patients with depression also experience significant anxiety; TMS may reduce both mood and anxiety symptoms. Postpartum-specific coverage varies.
- Insurance often tied to MDD criteria
- Non-drug option for med-sensitive patients
PTSD & Anxiety Disorders
Trials suggest potential benefit for certain anxiety-spectrum symptoms and PTSD. Protocols and coverage are not uniform.
- Often considered investigational by payers
- Sometimes used adjunctively with therapy
Migraine & Pain Syndromes
Different neuromodulation approaches (including single-pulse TMS or device-specific protocols) have been studied for migraine and pain; availability and coverage vary.
- Device-specific approvals differ from clinic TMS
- Prior authorization requirements are common
Who Is a Good Candidate?
Strong Candidates
- Depression diagnosis confirmed by a clinician
- Limited benefit or side effects from antidepressants
- Prefer a non-drug, office-based option
- Stable enough for outpatient care
Not Typically Eligible
- Metal implants/fragments near the head; certain implanted devices
- Active suicidality or recent substance misuse
- Specific neurological or cardiac conditions without clearance
Full candidacy and safety screening occur during your evaluation. See How It Works.
What to Expect
Session Basics
- ~20 minutes per visit, Monday–Friday
- No anesthesia; you’re awake and can drive afterward
- Return to work, school, or errands the same day
Results & Tracking
- Progress measured with validated rating scales
- Most notice improvements over several weeks
- Plan tailored by a psychiatrist/PMHNP
Find Out If TMS Is Right for You
We verify insurance benefits in 48 hours and can start treatment in **≤ 7 business days** after approval.
This page is educational and not medical advice. Coverage depends on your plan and current clinical guidelines.